Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Cory

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cell Death and Differentiation|February 9, 2023
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesisHai Vu Nguyen, Cassandra J Vandenberg, Mikara R Robati, et al.
Cell Death and Differentiation|August 12, 2017
Mnt modulates Myc-driven lymphomagenesisKirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al.
Cell Death & Disease|September 2, 2016
Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in miceRebecca A Bilardi, Natasha S Anstee, Stefan P Glaser, et al.
The FEBS Journal|March 3, 2018
Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesisSelma Tuzlak, Manuel D Haschka, Anna-Maria Mokina, et al.
Cell Death and Differentiation|November 5, 2016
Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr miceNatasha S Anstee, Cassandra J Vandenberg, Kirsteen J Campbell, et al.
Cell Death and Differentiation|November 25, 2018
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in miceNatasha S Anstee, Rebecca A Bilardi, Ashley P Ng, et al.
Cell Death and Differentiation|January 18, 2018
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cellsMark Mensink, Natasha S Anstee, Mikara Robati, et al.
Blood|July 16, 2010
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistanceKirsteen J Campbell, Mary L Bath, Marian L Turner, et al.
Blood Neoplasia|October 27, 2025
MNT: a new target for AMLKarla C Fischer, Veronique Litalien, Sarah T Diepstraten, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cell Death and Differentiation|February 9, 2023
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesisHai Vu Nguyen, Cassandra J Vandenberg, Mikara R Robati, et al.
Cell Death and Differentiation|August 12, 2017
Mnt modulates Myc-driven lymphomagenesisKirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al.
Cell Death & Disease|September 2, 2016
Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in miceRebecca A Bilardi, Natasha S Anstee, Stefan P Glaser, et al.
The FEBS Journal|March 3, 2018
Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesisSelma Tuzlak, Manuel D Haschka, Anna-Maria Mokina, et al.
Cell Death and Differentiation|November 5, 2016
Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr miceNatasha S Anstee, Cassandra J Vandenberg, Kirsteen J Campbell, et al.
Cell Death and Differentiation|November 25, 2018
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in miceNatasha S Anstee, Rebecca A Bilardi, Ashley P Ng, et al.
Cell Death and Differentiation|January 18, 2018
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cellsMark Mensink, Natasha S Anstee, Mikara Robati, et al.
Blood|July 16, 2010
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistanceKirsteen J Campbell, Mary L Bath, Marian L Turner, et al.
Blood Neoplasia|October 27, 2025
MNT: a new target for AMLKarla C Fischer, Veronique Litalien, Sarah T Diepstraten, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.
Pageof 4